Detection modes of ultrasound contrast agents;Mode de détection des produits de contraste échographique

Journal de Radiologie

Volumn 84, Issue 12 II, 2003, Pages 2013-2024

  Meuwly, J Y ^a   Correas, J M ^b   Bleuzen, A ^c   Tranquart, F ^c  

^a CH Vaudois   (Switzerland)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CHU BRETONNEAU   (France)

Author keywords

Contrast media; Doppler; Functional imaging; Non linear imaging; Quantification; Ultrasound

Indexed keywords

ALBUNEX; ECHO CONTRAST MEDIUM; ECHOVIST; FS 069; NC 100100; PERFLEXANE; PERFLUOROPENTANE; PERFLUTREN; SHU 508; SHU 563A; SONAVIST; SONOGEN; SONOVUE; UNCLASSIFIED DRUG;

CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; DRUG ELIMINATION; DRUG METABOLISM; ECHOCARDIOGRAPHY; ECHOGRAPHY; FUNCTIONAL ASSESSMENT; GAS; HUMAN; LUNG CIRCULATION; REVIEW;

ARTIFACTS; BIOPHYSICS; CONTRAST MEDIA; INJECTIONS; ULTRASONOGRAPHY;

EID: 1242317107     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
2. Gramiak R, Shah PM, Kramer DH. Ultrasound cardiography: contrast study in anatomy and function. Radiology 1969;92:939-48.
3. Bove A, Ziskin M. Ultrasonic detection of in vivo cavitation and pressure effects of high speed injection through catheters. Investigative Radiology 1969;3:236-41.
4. Kremkau FW, Gramiak R, Carstensen EL, Shah PM, Kramer H. Ultrasonic detection of cavitation at catheter tips. Am J Roentgenol 1970;110:177-83.
5. Ophir J, McWhirt RE, Maklad NF. Aqueous solutions as potential ultrasonic contrast agents. Ultrasonic Imag 1979;1:265-79.
6. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319-33.
7. Behan M, O'Connell D, Mattrey RF, Carney DN. Perfluorooctylbromide as a contrast agent for CT and sonography: preliminary clinical results. AJR Am J Roentgenol 1993;160:399-405.
8. Quay SC. Microbubble-based ultrasound contrast agents: the role of gas selection in microbubble persistence. J Ultrasound Med 1994;13:S9.
9. Epstein PS, Plesset MS. On the stability of gaz bubbles in liquid-gas solutions. J Chem Phys 1950;18:1505-09.
10. Fritzsch T, Hauff P, Heldmann D, Luders F, Uhlendorf V, Weitschies W. Preliminary results with a new liver-specific ultrasound contrast agent. Ultrasound in Med. & Biol. 1994;20:S137.
11. Schneider M, Bussat P, Barrau M-B, Arditi M, Yan F, Hybl E. Polymeric microballoons as ultrasound contrast agents: physical and ultrasonic properties compared with sonicated albumin. Invest Radiol 1992;27:134-9.
12. Unger EC, Lund PJ, Shen D-K, Fritz TA, Yellowhair D, New TE. Nitrogen-filled liposomes as a vascular US contrast agent: preliminary evaluation. Radiology 1992;185:453-6.
13. Correas JM, Foster FS, Harasiewicz KA, Moreau JF, Pourcelot L, Burns PN. Which parameters would influence ultrasound contrast imaging? Journal d'Echographie et de Médecine Ultrasonore 1998;2/3:245-9.
14. Goldberg BB, Liu BB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994;20:319-33.
15. Schlief R, Staks T, Mahler M, Rufer M, Fritzsch T, Seifert W. Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990;7:61-4.
16. Goldberg BB, Hilpert P, Burns P, et al. Hepatic tumors: signal enhancement of doppler US after intravenous injection of a contrast agent. Radiology 1990;177:713-7.
17. Leen E, Angerson WJ, Warren H et al. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report. Br J Surg 1994;81:252-4.
18. Ernst H, Hahn E, Balzer T. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound 1996;24:31-6.
19. Kedar RP, Cosgrove DO, Smith IE, Mansi JL. Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging. Radiology 1994;190:825-30.
20. Baz E, Madjar H, Reuss C, Vetter M, Hackeloer B, Holz K. The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy. Ultrasound Obstet Gynecol 2000;15:377-82.
21. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Investigative Radiology 1995;30:451-7.
22. de Jong N. Physics of microbubble scattering. In: Nanda NC SR, Goldberg BB, ed. Advances in echo imaging using contrast enhancement. Dordrecht: Kluwer Academic Publishers, 1997:39-64.
23. Forsberg F. Physics of ultrasound contrast agents. In: Goldberg B, ed. Ultrasound contrast agents. London: Martin Dunitz, 1997:9-19.
24. Steinbach GC. Contrast-specific instrumentation and its potential applications, in Trends in contrast media, by Thomsen HS, Muller RN, Mattrey RF, Springer Eds, 321-32.
25. Kabalnov A, Bradley J, Flaim S, et al. Dissolution of multicomponent microbubbles in the bloodstream: 1. Experiment. Ultrasound in Med. & Biol. 1998;24:751-60.
26. Kabalnov A, Klein D, Pelura T, Schutt E, Weers J. Dissolution of multicomponent microbubbles in the bloodstream: 1. Theory. Ultrasound in Med. & Biol. 1998;24:739-49.
27. Leighton TG. The acoustic bubble. Academic Press, San Diego, 1994.
28. Chang PP, Shung KK. Interactioon of ultrasound and contrast agents in Trends in contrast media, by Thomsen HS, Muller RN, Mattrey RF, Springer Eds, 311-20.
29. AIUM/NEMA: Standard for real-time display of thermal and mechanical acoustic output indices on diagnostic ultrasound equipment. Rockville, MD, American Institute of Ultrasound in Medicine, 1992.
30. de Jong N, Frinking PJ, Bouakaz A, Ten Cate FJ: Detection procedures of ultrasound contrast agents. Ultrasonics 2000;38:87-92.
31. De Jong N, Ten Cate FJ. New ultrasound contrast agents and technological innovations. Ultrasonics 1996;34:587-90.
32. Powers JE, Burns PN, Souquet J. Imaging instrumentation for ultrasound contrast agents. In Advances in echo imaging using contrast enhancement by Nanda NC, Schlief R, Goldberg BB, Kluwer Academic, 139-70.
33. Villarraga H, Foley D, Aeschenbacher B, Klarich K, Mulvagh S. Destruction of contrast microbubbles during ultrasound imaging at conventional power output. J Am Soc Echocardiography 1997;10:783-91.
34. Tiemann K, Pohl C, Schlosser T et al. Stimulated acoustic emission: pseudo-Doppler shifts seen during the destruction of nonmoving microbubbles. Ultrasound Med Biol 2000;26:1161-7.
35. Blomley M, Albrecht T, Cosgrove D. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508A: early experience. Radiology 1999;210:409-16.
36. Blomley M, Albrecht T, Cosgrove D, Jayaram V, Butler-Barnes J, Eckersley R. Stimulated acoustic emission in liver parenchyma with Levovist. Lancet 1998;351:568.
37. Burns P, Powers J, Hope Simpson D. Harmonic contrast enhanced Doppler as a method for elimination of clutter. In vivo duplex and color studies. Radiology 1993;189:285.
38. Correas J, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001;11:1316-28.
39. Tiemann K, Veltmann C, Ghanem A et al. The impact of emission power on the destruction of echo contrast agents and on the origin of tissue harmonic signals using power pulse-inversion imaging. Ultrasound Med Biol 2001;27:1525-33.
40. Wu J, Pepe J, Dewitt W. Nonlinear behaviors of contrast agents relevant to diagnostic and therapeutic applications. Ultrasound Med Biol 2003;29:555-62.
41. Thomas L, Quiroz K, Phillips P, Steins R, Holley G, Otsuki J. High resolution harmonic imaging of contrast agents with improved frame rates, in The sixth european symposium on ultrasound contrast imaging. Edited by Ten Cate F, de Jong N, Cosgrove D. Rotterdam, 2001, p 17.
42. Averkiou M, Skyba D, Bruce M, Powers J. Real time perfusion imaging with ultrasound contrast agents, in The fifth heart centre european symposium on ultrasound contrast imaging. Edited by Ten Cate F, de Jong N, Cosgrove D. Rotterdam, 2000, pp 9-12.
43. Averkiou M, Bruce M, Skyba D, Jensen S, Powers J. Low MI nonlinear imaging techniques for real-time detection of perfusion using contrast microbubbles, in The sixth european symposium on ultrasound contrast imaging. Edited by Ten Cate F, de Jong N, Cosgrove D. Rotterdam, 2001, pp 15-16.
44. Schlosser T, Pohl C, Kuntz-Hehner S, Omran H, Becher H, Tieman K. Echoscintigraphy: a new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography. Ultrasound Med Biol 2003;29:985-991.
45. Porter TR, Xie F, Li Li S, D'Sa A, Rafter P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J Am Soc Echocardiogr 1996;9:599-605.
46. Wei K, Jayaweera A, Firoozan S, Linka A, Skyba D, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administrated as a constant veinous infusion. Circulation 1998;97:473-83.
47. Forsberg F, Liu J, Burns P. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 1994;13:357-65.
48. Burns P, Powers J, Hope Simpson D. Harmonic imaging and Doppler using microbubble contrast agents: a new method for contrast imaging. Ultrasound Med Biol 1994;20:S72.
49. Frauscher F, Janetschek G, Helweg G. Crossing vessels at the ureteropelvic junction: detection with contrast-enhanced color Doppler imaging. Radiology 1999;210:727-31.
50. Deichert U, Schlief R, van de Sandt M, Juhnke I. Transvaginal hysterosalpingo-contrast-sonography (Hy-Co-Sy) compared with conventional tubal diagnostics. Hum Reproduct 1989;4:418-24.
51. Darge K, Troeger J, Duetting T, Zieger B, Rohrschneider W, Moehring K, Weber C, Toenshoff B. Reflux in young patients: comparison of voiding US of the bladder and retrovesical space with echo enhancement versus voiding cystourethrography for diagnosis. Radiology 1999;210:201-7.
52. Gebel M, Caselitz M, Bowen-Davies P, Weber S. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SHU 508A (Levovist®) for Doppler signal enhancement in the portal vascular system. Ultraschall in Med 1998;19:148-56.
53. Ricci P, Cantisani V, Biancari F et al. Contrast-enhanced color Doppler US in malignant portal vein thrombosis. Acta Radiol 2000;41:470-3.
54. Goldberg BB, Hilpert PL, Burns PN et al. Hepatic tumors: signal enhancement at Doppler US after intravenous injection of a contrast agent. Radiology 1990;177:713-7.
55. Hosten N, Puls R, Lemke A-J. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound 1999;27:107-15.
56. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71.
57. Albrecht T, Blomley MJ, Burns PN et al. Improved Detection of Hepatic Metastases with Pulse-Inversion US during the Liver-specific Phase of SHU 508A: Multicenter Study. Radiology 2003;227:361-70.
58. Meuwly J, Schnyder P, Gudinchet F, Denys A. Pulse-inversion harmonic imaging improves lesion conspicuity during US-guided biopsy. J Vasc Interv Radiol 2003;14:1-7.
59. Bertolotto M, Dalla Palma L, Quiaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000;10:1369-76.
60. Harvey J, Blomley M, Eckersley R, Heckermann R, Butler-Barnes J, Cosgrove D. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetric metastases. Lancet 2000;355:807-8.
61. Harvey C, Blomley M, Eckersley R et al. Hepatic malignancies: improved detection with pulse-inversion US in the late phase of enhancement with SHU 508A-Early experience. Radiology 2000;216:903-8.
62. Desir RM, Cheirif JB, Bolli R, al. Assessment of regional myocardial perfusion with myocardial contrast echocardiography in a canine model of varying degrees of coronary stenosis. Am Heart J 1994;127:56-63.
63. Correas J, Lefevre F, Hélénon O, Claudon M. Functional imaging of renal transplant using contrast-enhanced sonography with trigged pulse inversion imaging: results of a pilot study, in The Fifth Heart Centre European Symposium on Ultrasound Contrast Imaging. Rotterdam, Ten Cate, FJ. de Jong, N. Cosgrove, DO., 2000, pp 23.
64. Wilkening W, Postert T, Federlein J, Kono Y, Mattrey R, Ermert H. Ultrasonic Assessment of Perfusion Conditions in the Brain and in the Liver, in IEEE Ultrasonics Symposium, 2000, pp PW-8.
65. Lucidarme O, Franchi-Abella S, Correas JM, Bridal SL, Kurtisovski E, Berger G. Blood flow quantification with contrast-enhanced US: "Entrance in the section" phenomenon - phantom and rabbit study. Radiology 2003;228:473-9.
66. Kaul S. New developments in ultrasound systems for contrast echocardiography. Clin Cardiol 1997;20S1:127-30.